Wanted Lab, the operator of an AI-based recruitment platform “Wanted”, has been listed on the KOSDAQ market on August 11.


The company plans to use the raised funds for mergers and acquisitions to expand business opportunities, develop new/overseas businesses, and secure R&D talent.


The company has confirmed the IPO price at KRW 35,000 ($30) based on the results of the demand forecast conducted through 1597 institutional investors who have participated in this demand forecast, recording a competition of 1504 to 1. 


Additionally, about 99% of participating institutions wrote down their offering price above the upper end of the desired range, and the total amount of the public offering was confirmed to be at KRW 256B ($220M).



Wanted Lab attributed this high valuation to its unique data, AI recruitment matching technology, and future growth potential of the company.


Established in 2015, the company quickly entered the job market by introducing the recruitment platform “Wanted” as a business model for 'recruitment through acquaintances'. Currently, they are providing an AI-based recruitment service for more than 2.2 million real-time matching result data in 5 Asian countries, including Korea. 


Last year, the sales exceeded the KRW 10B ($8M) mark for the first time since its establishment, and the earnings are continuing to rise this year with sales in the first quarter having increased 93% to KRW 5.7B ($5M) from the same period of the previous year.


Wanted Lab CEO Bokkee Lee said, "I would like to thank all institutional investors who showed interest in Wanted Lab and participated in the demand forecasting. We will continue to provide diversified HR solutions to companies and become recognized on the global market."


Alchera, an AI image recognition startup and a member company of Born2Global Centre, has revealed its strategy and vision just before being listed on the KOSDAQ market as of December 21.


Alchera provides a complete solution that covers collecting and editing of large-capacity image data, deep learning, AI engine optimization, and creation of dedicated solutions. The solution has secured an unrivaled position among major domestic customers as it excels in facial recognition, augmented reality (AR), anomaly detection, and data business.


Alchera's core competitiveness lies in its source technology for artificial intelligence facial recognition and anomaly detection. Alchera's AI can recognize not only human expressions but also subtle abnormal signs of objects with an accuracy of 99% or more. Instant recognition is also available.


The company has achieved grade A standards in both a technical evaluation by eCredible Co., Ltd., a specialized rating service provider, and an evaluation by Korea Enterprise Data Co., Ltd. Alchera's technological excellence has been shown when their technology was successfully applied to Shinhan Face Pay, known as Korea's first facial recognition payment system


Image recognition technology is being used in various industrial fields. Since this was first applied to the Snow Camera in 2016, it has been applied to Incheon International Airport's Automated Immigration System, the Passport Information Comprehensive Administration System of the Ministry of Foreign Affairs, the passport counterfeit detection system of the Korean financial industry, and the fire monitoring system of KEPCO. The company achieved a high level of market recognition as a result of its successfully established references.


Alchera recently launched a facial recognition-based entry control system with its own algorithm called Alchera ACS that has aggressively entered domestic and international markets. Following the KC and CE certifications, the system is waiting for certification from the Ministry of Food and Drug Safety.


Young-kyoo Hwang, CTO of Alchera, said, "In the non-face-to-face era and a trend of non-contact service, AI image recognition technology is attracting attention as an optimization solution in various areas including payment and public services, financial industry, medical services, entry control, and security services. The company expects a steep increase in sales in the future due to Alchera's source technology being a strong barrier to entry for overseas competitors who have yet to produce a similar product." He added, "The listing on the KOSDAQ is expected to be a turning point for Alchera to leap higher". He also mentioned, "We will do our best to transform into a global AI image recognition company that leads trends in various industries thanks to our overwhelmingly innovative technology."


By Hyunjin Choi


JLK Inspection, an AI-enhanced medical solution provider, announced that it will seek Initial Public Offering(IPO) to go public on KOSDAQ, submitting the registration statement to the Financial Services Commission after passing the preliminary screening review by Korean Exchange(KRX) on the 30th last month.


The market is eyeing on JLK Inspection in the process of IPO under the technology exception policy since it will be the first AI-based medical company on the KOSDAQ market. The company plans to secure approximately a maximum of KRW 29 bn (USD 25 mm) by offering 2 million stocks with the IPO price band between 11,000 won and 14,500 won per share.


The IPO price is to set up during the book-building session on Nov. 26-27. Public subscriptions will be held on Dec. 2-3, and JLK Inspection expects that the listing is finalized within this year. The lead manager is Korea Investment & Securities Co.



Founded in 2014, JLK Inspection(a Born2Global member from 2017~2019) is a medical solutions provider specializing AI-enhanced technology.


The company released AIHuB, an all-in-one medical platform to detect 37 medical conditions in 14 different body parts: strokes, Alzheimer’s, prostate cancer, lung cancer, thyroids cancer, breast cancer, and joint disease. To support a doctor’s diagnosis, AIHuB analyzes nationwide scales of MR images up to 1.5M slides from 14K people based on deep learning technology. After the analysis, it provides a real-time diagnosis support on site for practitioners.


While competitors use only CT to detect diseases, AIHuB heightens the accuracy, using CT, MRI, MRA, and mammography data all together.These solutions are approved by the Ministry of Food and Drug Safety in South Korea as an AI-based class Ⅲ computer aided diagnosis system. It has obtained CE mark for AI-based medical solutions in accordance with the European Medical Device Directive(MDD).


Newsletter Sign Up

By clicking "submit," you agree to receive emails from Bron2Global and accept our web terms of use and privacy and cookie policy*Terms apply.